Cargando…

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells

Therapeutic targeting of the estrogen receptor (ER) is a clinically validated approach for estrogen receptor positive breast cancer (ER+ BC), but sustained response is limited by acquired resistance. Targeting the transcriptional coactivators required for estrogen receptor activity represents an alt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bommi-Reddy, Archana, Park-Chouinard, Sungmi, Mayhew, David N., Terzo, Esteban, Hingway, Aparna, Steinbaugh, Michael J., Wilson, Jonathan E., Sims, Robert J., Conery, Andrew R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967035/ https://www.ncbi.nlm.nih.gov/pubmed/35353838 http://dx.doi.org/10.1371/journal.pone.0262378

Ejemplares similares

Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors
por: Crawford, McKenna C., et al.
Publicado: (2023)

CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300 mutated lymphomas
por: Veazey, Kylee J., et al.
Publicado: (2020)

Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function
por: Kumar, Manish, et al.
Publicado: (2021)

Aspirin induces autophagy via inhibition of the acetyltransferase EP300
por: Castoldi, Francesca, et al.
Publicado: (2018)

The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
por: Zhu, Yu, et al.
Publicado: (2023)

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300
por: Williams, Lynn M., et al.
Publicado: (2020)

CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation
por: Garcia-Carpizo, Veronica, et al.
Publicado: (2018)

CREBBP and EP300 mutational spectrum and clinical presentations in a cohort of Swedish patients with Rubinstein–Taybi syndrome
por: Wincent, Josephine, et al.
Publicado: (2015)

Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP
por: Qian, Maoxiang, et al.
Publicado: (2017)

Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report
por: Al-Qattan, Mohammad M., et al.
Publicado: (2019)

Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma
por: Nie, Man, et al.
Publicado: (2021)

High affinity between CREBBP/p300 and NCOA evolved in vertebrates
por: Karlsson, Elin, et al.
Publicado: (2020)

Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice
por: Zheng, Fei, et al.
Publicado: (2016)

Structure of the p300 Histone Acetyltransferase Bound to Acetyl-Coenzyme A and Its Analogues
por: Maksimoska, Jasna, et al.
Publicado: (2014)

Make the right measurement: Discovery of an allosteric inhibition site for p300-HAT
por: Gardberg, Anna S., et al.
Publicado: (2019)

Inhibition of histone acetyltransferase (HAT) activity by HBZ extends beyond the p300/CBP HAT family
por: Wright, Diana G, et al.
Publicado: (2014)

Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells
por: Gao, Chao, et al.
Publicado: (2020)

Transcription factor dimerization activates the p300 acetyltransferase
por: Ortega, Esther, et al.
Publicado: (2019)

FOXA1 inhibits prostate cancer neuroendocrine differentiation
por: Kim, Jung, et al.
Publicado: (2017)

Snail acetylation by histone acetyltransferase p300 in lung cancer
por: Chang, Rui, et al.
Publicado: (2017)

Short-chain fatty acids activate acetyltransferase p300
por: Thomas, Sydney P, et al.
Publicado: (2021)

Structural basis for binding diversity of acetyltransferase p300 to the nucleosome
por: Hatazawa, Suguru, et al.
Publicado: (2022)

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
por: Huang, Yao-Hui, et al.
Publicado: (2021)

No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer
por: Campbell, Ian G, et al.
Publicado: (2004)

miRNA-132-3p inhibits osteoblast differentiation by targeting Ep300 in simulated microgravity
por: Hu, Zebing, et al.
Publicado: (2015)

Acetyltransferase p300 inhibitor reverses hypertension‐induced cardiac fibrosis
por: Rai, Rahul, et al.
Publicado: (2019)

Carnosol Is a Novel Inhibitor of p300 Acetyltransferase in Breast Cancer
por: Alsamri, Halima, et al.
Publicado: (2021)

Diabetes and Its Cardiovascular Complications: Potential Role of the Acetyltransferase p300
por: Di Pietrantonio, Nadia, et al.
Publicado: (2023)

HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis
por: Emmons, Michael F., et al.
Publicado: (2023)

Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis
por: Holmstrom, Sam R., et al.
Publicado: (2019)

Structural elucidation of substrate-bound aminoglycoside acetyltransferase (3)-IIIa
por: Zieliński, Michał, et al.
Publicado: (2022)

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022)

6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
por: Kawase, Yuto, et al.
Publicado: (2023)

Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutation
por: Luo, Mayao, et al.
Publicado: (2023)

Spatiotemporal expression of histone acetyltransferases, p300 and CBP, in developing embryonic hearts
por: Chen, Guozhen, et al.
Publicado: (2009)

Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
por: Valor, Luis M, et al.
Publicado: (2013)

Endotoxemia-mediated activation of acetyltransferase P300 impairs insulin signaling in obesity
por: Cao, Jia, et al.
Publicado: (2017)

Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity
por: Nishimura, Yuhei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kive9gc6r9r3a09a414pcifreu